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Abstract
Disrupted circadian rhythms and reduced sleep duration are associated with several human
diseases, particularly obesity and type 2 diabetes, but until recently, little was known about
the genetic factors influencing these heritable traits. We performed genome-wide associa-
tion studies of self-reported chronotype (morning/evening person) and self-reported sleep
duration in 128,266 white British individuals from the UK Biobank study. Sixteen variants
were associated with chronotype (P<5x10-8), including variants near the known circadian
rhythm genes RGS16 (1.21 odds of morningness, 95% CI [1.15, 1.27], P = 3x10-12) and
PER2 (1.09 odds of morningness, 95% CI [1.06, 1.12], P = 4x10-10). The PER2 signal has
previously been associated with iris function. We sought replication using self-reported data
from 89,283 23andMe participants; thirteen of the chronotype signals remained associated
at P<5x10-8 on meta-analysis and eleven of these reached P<0.05 in the same direction in
the 23andMe study. We also replicated 9 additional variants identified when the 23andMe
study was used as a discovery GWAS of chronotype (all P<0.05 and meta-analysis
P<5x10-8). For sleep duration, we replicated one known signal in PAX8 (2.6 minutes per
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allele, 95% CI [1.9, 3.2], P = 5.7x10-16) and identified and replicated two novel associations
at VRK2 (2.0 minutes per allele, 95% CI [1.3, 2.7], P = 1.2x10-9; and 1.6 minutes per allele,
95% CI [1.1, 2.2], P = 7.6x10-9). Although we found genetic correlation between chronotype
and BMI (rG = 0.056, P = 0.05); undersleeping and BMI (rG = 0.147, P = 1x10-5) and over-
sleeping and BMI (rG = 0.097, P = 0.04), Mendelian Randomisation analyses, with limited
power, provided no consistent evidence of causal associations between BMI or type 2 dia-
betes and chronotype or sleep duration. Our study brings the total number of loci associated
with chronotype to 22 and with sleep duration to three, and provides new insights into the
biology of sleep and circadian rhythms in humans.
Author Summary
Numerous studies have identified links between too little or too much sleep and circadian
misalignment with metabolic disorders such as obesity and type 2 diabetes. However,
cause-and-effect is not easily determined, because of multiple confounding factors affect-
ing both sleep patterns and disease risk. Using the first release of the UK Biobank study,
which combines detailed measurements and questionnaire data with genetic data, we
investigate the genetics of two self-report sleep measures, chronotype and average sleep
duration, in 128,266 white British individuals. We replicate previous genetic associations
and identify seven and two novel genetic variants influencing chronotype and sleep dura-
tion, respectively. Associated variants are located near genes implicated in circadian
rhythm regulation (RGS16, PER2), near a serotonin receptor gene (HTR6) and another
gene (INADL) encoding a protein thought to be important in photosensitive retinal cells,
cells known to communicate with the brain’s primary circadian pacemaker. Using the
genetic risk factors, we estimate the unconfounded causal associations of BMI and type 2
diabetes on sleep patterns (and vice versa) through Mendelian Randomisation. However,
we find no evidence for causal associations in either direction. The full UK Biobank release
of 500,000 individuals will boost our power to detect causal associations.
Introduction
There are strong epidemiological associations between disrupted circadian rhythms, sleep dura-
tion and disease. A circadian rhythm refers to an underlying 24-hour physiological cycle that
occurs in most living organisms. In humans, there are clear daily cyclical patterns in core body
temperature, hormonal and most other biological systems [1]. These cycles are important for
many molecular and behavioural processes. In particular, circadian rhythms are important in
regulating sleeping patterns. While each individual has an endogenous circadian rhythm, the
timing of these rhythms varies across individuals. Those with later circadian rhythms tend to
sleep best with a late bedtime and late rising time and are often referred to as an “owl” or as an
“evening” person. Those with earlier rhythms tend to feel sleepy earlier in the night and wake up
early in the morning and are referred to as a “lark” or “morning” person. The remainder of the
population falls in between these extremes. This dimension of circadian timing, or chronotype, is
one behavioural consequence of these underlying cycles. Chronotype can be simply assessed by
questionnaire and is considered a useful tool for studying circadian rhythms [2,3].
There is substantial evidence for a relationship between short sleep duration, poor quality
sleep and obesity and type 2 diabetes [4,5]. Eveningness has been associated with poor
GWAS of Morningness and Sleep Duration Discovers New Loci
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glycaemic control in patients with type 2 diabetes independently of sleep disturbance [6] and
with metabolic disorders and body composition in middle-aged adults [7]. There is evidence
from animal models that disruption to circadian rhythms and sleep patterns can cause various
metabolic disorders [8–10]. For example, mice homozygous for dominant negative mutations
in the essential circadian gene, Clock, develop obesity and hyperglycaemia [10] and conditional
ablation of the Bmal1 and Clock genes in pancreatic islets causes diabetes mellitus due to defec-
tive β-cell function [9]. Despite this evidence, in humans the causal nature of the epidemiologi-
cal associations between sleep patterns, circadian rhythms and obesity and type 2 diabetes is
unknown. Identifying genetic variants associated with sleep duration and chronotype will pro-
vide instruments to help test the causality of epidemiological associations [11].
A previous genome-wide association study (GWAS) in 4,251 individuals identified a single
genetic variant in ABCC9 associated with sleep duration [12]. A subsequent GWAS meta-anal-
ysis including 47,180 individuals identified a single locus for sleep duration near PAX8 [13].
Fifteen loci associated with chronotype were recently discovered by 23andMe [14] with 7 of
these found to be in close proximity to known circadian rhythm regulation genes. The UK Bio-
bank is a study of 500,000 individuals from the UK aged between 37 and 73 years with
genome-wide SNP analysis and detailed phenotypic information, including chronotype and
sleep duration (http://www.ukbiobank.ac.uk/). The UK Biobank study provides an excellent
opportunity to identify novel genetic variants influencing chronotype and sleep duration
which will provide insights into the biology of circadian rhythms and sleep and help test causal
relationships between circadian rhythm and metabolic traits including obesity.
Results
Sixteen loci associated with chronotype in UK Biobank
Using self-reported “morningness”, we generated a binary and a continuous chronotype score.
We performed genome-wide association studies on 16,760,980 imputed autosomal variants.
Fig 1 presents the overall results for these GWAS. Table 1 presents details of all 16 loci associ-
ated at P<5x10-8.
Replication and validation of UK Biobank chronotype associations
Analysing UK Biobank data with that from 23andMe provides evidence that at least 13 of the
16 are associated with chronotype. Thirteen of the chronotype signals remained at P<5x10-8 in
a meta-analysis including UK Biobank and 89,283 individuals from 23andMe [14], of which 11
reached P<0.05 in the same direction in 23andMe alone, and 15 of the 16 UK Biobank signals
were in the same direction (binomial P = 0.0002) (Table 1). We also attempted to validate the
associations in 6,191 European-Ancestry from the Chronogen consortium and 2,532 Korean
Ancestry individuals from the Insomnia, Chronotype and sleep EEG (ICE) consortium that
used “Gold standard” chronotype questionnaire (Munich Chronotype Questionnaire–MCTQ
and Morningness-Eveningness Questionnaire—MEQ). Given the sample size of 5% of the
discovery UK Biobank study we assessed directional consistency rather than testing for re-
plication P-values<0.05 or 0.05/16. In the European-Ancestry individuals 11 of the 16 signals
were represented. Nine of these 11 variants had the same direction of effect as the discovery
UK Biobank cohort (binomial test P = 0.03) and one replicated at Bonferroni significance
(rs12140153, P = 0.003). In the Korean study, 9 signals were represented, four of which had
the same direction of effect as the discovery UK Biobank cohort (binomial test P = 1.00). The
level of directional consistency in these two smaller studies is consistent with what would be
expected in cohorts<5% the size of our discovery cohort.
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Replication of previously reported chronotype associations
A 23andMe study recently identified 15 loci associated with chronotype [14]. All of the 15 sig-
nals were replicated in our study with P<0.05 in the same direction and had meta-analysis
P<5x10-8 (S1 Table). We performed a conditional analysis of our lead chronotype variants by
adjusting for the 15 known signals (S2 Table), in order to identify which of our loci coincided
with those of Hu et al. [14]. Seven of our 13 replicated signals remained associated at P<5x10-8
(see Table 1). The addition of these 7 loci brings the number associated with chronotype to 22
(full list in S3 Table).
The chronotype-associated variants occur near genes known to be
important in photoreception and circadian rhythms
The variant most strongly associated with chronotype, rs516134 (OR for morningness = 1.21,
95% CI [1.16, 1.26], binary P = 3.7x10-12, continuous P = 8.9x10-13) occurs near RGS16, which
is a regulator of G-protein signalling and has a known role in circadian rhythms [16] (Table 1
Fig 1. Manhattan and quantile-quantile (QQ) plots for chronotype. Summary information plots for inverse-normalised (self-report)
chronotype score vs. ~16.8 million imputed genetic variants in 127,898White British individuals in the UK Biobank study. The Manhattan
plot (top) shows association test (-log10 P-value on the y-axis against physical autosomal location on the x-axis. The standard genome-
wide significance cutoff of P = 5x10-8 is shown by the horizontal black line. Variants tested had imputation R2>0.4, a Hardy-Weinberg
Equilibrium (HWE) P-value > 1x10-6 and minor allele frequency (MAF) > 0.1%. The QQ (quantile-quantile) plot (bottom) identifies some
inflation (λGC = 1.097) but this is consistent with expected inflation from a highly polygenic trait in such a large sample size [15].
doi:10.1371/journal.pgen.1006125.g001
Table 1. Genetic variants associated with chronotype (as either a continuous or binary trait) at P<5x10-8 in the UK Biobank study. Variants
highlighted in bold were not identified by the 23andMe study, those in italic did not reach genome-wide significance on meta-analysis and those not
highlighted replicate previously reported loci from 23andMe. Genes listed are candidate or nearest genes within 250Kb of the lead SNP. Odds ratios corre-
spond to risk of morningness over eveningness. Beta, OR and frequency refers to A1. Replication data is based on continuous data and as the replication
beta is in different units to the discovery GWAS beta, a P-value meta-analysis was performed.
Variant Chr:Pos
(b37)
A1/A2 A1
Freq
GWAS
Continuous Beta
(SE)
GWAS
Continuous P
GWAS
Binary OR
(SE)
GWAS
Binary P
Replication
Beta (SE)
Replication
P
Combined
P
Genes
rs516134 1:182,553,693 C/T 0.03 0.081 (0.011) 9.00E-13 1.21 (0.032) 3.00E-12 0.295 (0.035) 2.00E-17 7.00E-28 RGS16
rs11162296 1:77,700,196 G/C 0.84 -0.037 (0.005) 2.00E-12 0.93 (0.011) 1.00E-12 -0.097 (0.015) 2.00E-10 2.00E-21 PIGK, AK5
rs10157197 1:150,250,636 G/A 0.6 0.025 (0.004) 1.00E-09 1.05 (0.010) 5.00E-07 0.064 (0.011) 1.00E-08 6.00E-17 PRPF3,
TARS2
rs372229746 * 7:102,158,815 G/A 0.55 0.028 (0.005) 4.00E-09 1.06 (0.012) 7.00E-07 0.068 (0.013) 4.00E-07 8.00E-15 ORAI2,
RASA4
rs75804782 2:239,316,043 T/C 0.88 0.030 (0.006) 3.00E-07 1.09 (0.015) 4.00E-10 0.106 (0.018) 4.00E-09 1.00E-14 PER2
rs76899638 6:55,147,508 A/ATG 0.22 0.026 (0.005) 4.00E-08 1.05 (0.012) 2.00E-07 0.067 (0.014) 4.00E-06 8.00E-13 HCRTR2
rs77641763 9:140,265,782 C/T 0.88 0.039 (0.006) 5.00E-11 1.07 (0.015) 7.00E-09 0.065 (0.020) 2.00E-03 2.00E-12 EXD3
rs9961653 18:56,767,671 T/C 0.42 0.023 (0.004) 1.00E-08 1.04 (0.010) 1.00E-06 0.032 (0.012) 6.00E-03 7.00E-10 RAX,
CPLX4,
LMAN1
rs2050122 1:19,989,205 T/C 0.2 0.028 (0.005) 2.00E-08 1.06 (0.012) 3.00E-06 0.030 (0.014) 3.00E-02 1.00E-08 HTR6
rs70944707 * 2:24,257,444 C/CT 0.23 0.030 (0.005) 3.00E-08 1.05 (0.013) 2.00E-05 0.035 (0.016) 3.00E-02 2.00E-08 FKBP1B
rs72720396 1:91,191,582 A/G 0.77 -0.025 (0.005) 1.00E-07 0.95 (0.010) 3.00E-08 -0.035 (0.014) 2.00E-02 2.00E-08 CALB1
rs12140153 1:62,579,891 G/T 0.9 0.039 (0.007) 7.00E-09 1.07 (0.017) 4.00E-06 0.043 (0.025) 8.00E-02 3.00E-08 INADL
rs1075265 2:54,354,927 C/G 0.48 -0.025 (0.004) 2.00E-10 0.95 (0.009) 4.00E-08 -0.010 (0.011) 4.00E-01 4.00E-08 PSME4,
ACYP2
rs4821940 22:40,659,573 T/C 0.45 0.022 (0.004) 3.00E-08 1.05 (0.010) 4.00E-08 0.006 (0.011) 6.00E-01 5.00E-06 SGSM3
rs12635074 3:55,982,416 T/G 0.68 -0.023 (0.004) 3.00E-08 0.96 (0.009) 2.00E-06 -0.002 (0.012) 8.00E-01 1.00E-05 ERC2
rs192534763 8:36,202,946 T/C 0.99 0.100 (0.021) 3.00E-07 1.25 (0.057) 2.00E-08 -0.005 (0.055) 9.00E-01 1.00E-04 UNC5D
* Proxies used for replication cohort: rs4729854 for rs372229746 (r2 = 0.33), and rs12621152 for rs70944707 (r2 = 0.33).
doi:10.1371/journal.pgen.1006125.t001
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and Fig 2). Another signal occurs near PER2 (lead variant rs75804782, OR = 1.09, 95% CI
[1.06, 1.12], binary P = 7.2x10-10, continuous P = 3.2x10-7; Fig 3). PER2 is a well-known regula-
tor of circadian rhythms [17–22] and contains a variant, rs75804782, recently shown to be
associated with iris formation [23] that is in LD (r2 = 0.65, D’ = 0.97) with our reported lead
SNP. As there is a reported link between season and reported chronotype [24], we carried out a
sensitivity analysis in which we adjusted for month of attendance (to assessment centre); all
associations remained genome-wide significant for the reported variants. We tested for enrich-
ment of specific biological and molecular pathways using MAGENTA (Meta-Analysis Gene-
set Enrichment of variaNT Associations) [25] but none had a clear link to circadian rhythms
(S4 Table).
Three loci associated with sleep duration
We performed genome-wide association studies on a binary sleep phenotype and a continuous
sleep duration score for 16,761,225 imputed variants. Fig 4 presents the overall results for these
GWAS. Three loci reached genome-wide significance. The most strongly associated variant
was rs62158211 with an average 2.6 minute (95% CI [1.9, 3.2], P = 5.7x10-16) per-allele change
Fig 2. LocusZoom plot of chronotype associations in the RGS16 locus. The plot displays -log10 P-value on the y-axis and physical position on the x-
axis. Points identify individual variants whose colour indicates their LD r2 with lead variant rs516134. The blue line indicates pre-calculated recombination
rates (in cM/Mb) at each position. Variants with association P-values > 0.01 were omitted for clarity.
doi:10.1371/journal.pgen.1006125.g002
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in sleep duration and occurs at the previously reported association signal near PAX8 [13]. We
identified two, novel, conditionally independent, signals that were located ~900kb apart, one
upstream and the other downstream of VRK2. The downstream variant, rs17190618, has an
average per allele effect of 2.0 minutes (95% CI [1.3, 2.7], P = 1.2x10-9) on sleep duration. The
upstream variant, rs1380703 (which is not correlated with rs17190618, r2 = 0.002), has an average
per allele effect of 1.6 minutes (95% CI [1.1, 2.2], P = 7.6x10-9) on sleep duration. On adjusting
for month of assessment, we saw similar associations for both rs62158211 (P = 3x10-16) and
rs1380703 (P = 6x10-9), with no change for rs17190618. Table 2 shows the three sleep duration
loci and their lead variants. Fig 5 shows locus zoom plots of the VRK2 association signals. We
did not replicate the association of a previously reported variant in ABCC9 [12] with sleep dura-
tion (rs11046205, 0.1mins, 95% CI [-0.6, 0.7], P = 0.83).
Replication of novel sleep duration hits
To replicate the two novel sleep duration hits we used data from 47,180 individuals from a pub-
lished study [13]. The variant rs17190618 replicated with effect size = 2.1 minutes (95% CI
[0.8, 3.3], P = 0.001, meta-analysis P = 5x10-12). The variant rs1380703 replicated with effect
size = 1.3 minutes (95% CI [0.3, 2.2], P = 0.01, meta-analysis P = 3x10-10).
Fig 3. LocusZoom plot of chronotype associations in the PER2 locus. Variants are coloured by their LD r2 with lead variant rs75804782 and those
with association P-values > 0.01 were omitted for clarity.
doi:10.1371/journal.pgen.1006125.g003
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Sleep duration and chronotype are heritable and genetically correlated
with BMI and psychiatric disease
Using LD-score regression we estimated the heritability of chronotype and sleep duration
within UK Biobank to be 0.12 (0.007), and 0.07 (0.007), respectively. There was no evidence of
a genetic correlation between sleep duration and chronotype (rG = 0.0177, P = 0.70). Chrono-
type was nominally genetically correlated with BMI (rG = 0.056, P = 0.048), but not Type 2 dia-
betes (rG = 0.004, P = 0.99). As the relationship between sleep duration with BMI and risk of
T2D is U-shaped (see S1 Fig), we defined two further binary phenotypes; undersleepers (<7
vs. 7–8 hours) and oversleepers (>8 vs. 7–8 hours). There was a strong genetic correlation
between undersleeping and BMI (rG = 0.147, P = 1x10-5), but not T2D (rG = 0.022,P = 0.79).
There was also a genetic correlation between oversleeping and both BMI (rG = 0.097,
P = 0.039) and T2D (rG = 0.336, P = 0.001). We also performed LD-score regression analyses
against a range of other diseases and traits where GWAS summary statistics are publicly avail-
able (S5 Table). Schizophrenia was genetically correlated (after adjusting for the number of
tests) with hours slept (rG = 0.26, P = 5x10-10), oversleeping (rG = 0.35, P = 6x10-8), under-
sleeping (rG = -0.14, P = 2x10-3) and chronotype (rG = -0.12, P = 2x10-4).
Mendelian randomisation analyses provide no consistent evidence that
higher BMI affects self-reported morningness or vice-versa
The genetic correlations we observed provide general estimates that capture pleiotropic vari-
ants (those that affect both traits through different pathways) and associations that are second-
ary to a variant affecting a trait that causally influences the second trait. Using a genetic risk
score of 69 known BMI variants [26] (listed in S6 Table) as an instrumental variable, we next
performed Mendelian randomisation analyses in the UK Biobank study to test the potential
causal role of BMI in chronotype and sleep. Instrumental variables analyses using variants and
their effect sizes identified by previous studies [26] provided no consistent evidence that BMI
causally affects self-reported “morningness” (S7 Table). Association statistics of the BMI vari-
ants with chronotype are given in S6 Table. We repeated these analyses using a genetic risk
score consisting of 55 type 2 diabetes SNPs [27] and did not find any evidence of causality. Per-
forming the reciprocal Mendelian randomization analysis using a genetic risk score of the 13
replicated chronotype variants, with effect sizes obtained from 23andMe, we found no consis-
tent evidence in the UK Biobank data that morningness or eveningness leads to higher BMI
(S7 Table). Association of the chronotype-associated variants with BMI are given in S8 Table.
Fig 4. Manhattan and quantile-quantile (QQ) plots for chronotype. Summary information plots for inverse-normalised (self-report)
Sleep Duration vs. ~16.8 million imputed genetic variants in 127,573White British individuals in the UK Biobank study. The Manhattan plot
(top) shows association test (-log10 P-value on the y-axis against physical autosomal location on the x-axis with the standard genome-wide
significance cutoff of P = 5x10-8 shown by the horizontal black line. Variants tested had imputation R2>0.4, a Hardy-Weinberg Equilibrium
(HWE) P-value > 1x10-6 and minor allele frequency (MAF) > 0.1%. The Sleep Duration QQ plot (bottom) identifies some inflation (λGC =
1.097) but, as with Chronotype, this is consistent with expected inflation from a highly polygenic trait in such a large sample size [15].
doi:10.1371/journal.pgen.1006125.g004
Table 2. Three loci associated with sleep duration and their lead variants. Genes listed are candidate genes at each locus. Beta, OR and frequency
refers to A1. Because the replication beta is in different units to the discovery GWAS beta, a P-value meta-analysis was performed. Beta units are in hours.
Variant Chr:Pos (b37) A1/
A2
A1
Freq
GWAS
Continuous
Beta (SE)
GWAS
Continuous P
GWAS
Binary OR
(SE)
GWAS
Binary P
Replication
Beta (SE)
Replication
P
Combined
P
Gene
rs62158211 2:114,106,139 G/T 0.79 -0.039 (0.005) 6E-16 0.94 (0.011) 1E-07 -0.053 (0.009) 4E-9 2E-23 PAX8
rs17190618 2:58,882,765 A/T 0.84 -0.033 (0.005) 1E-09 0.96 (0.013) 3E-04 -0.035 (0.011) 1E-3 5E-12 VRK2
rs1380703 2:57,941,287 A/G 0.62 0.025 (0.004) 8E-09 1.06 (0.011) 8E-08 0.021 (0.008) 1E-2 3E-10 VRK2
doi:10.1371/journal.pgen.1006125.t002
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No evidence that BMI and type 2 diabetes are causally associated with
sleep duration
Using the same genetic risk score of 69 known BMI variants as an instrument, we saw no con-
sistent evidence that higher BMI increased an individual’s likelihood of being an undersleeper
(IVreg2 P = 0.95, IVW P = 0.04) or an oversleeper (IVreg2 P = 0.29, IVW P = 0.62) in the UK
Biobank data (S7 Table). Because there were only three genetic variants of small effect associ-
ated with sleep duration, we did not perform any Mendelian Randomisation analyses of sleep
on BMI or type 2 diabetes risk.
Discussion
We performed a genome-wide association study of sleep duration and morningness in 128,266
individuals from the UK Biobank study. We discovered and replicated two novel loci associated
with sleep duration. Through replication in a study of 89,823 individuals from 23andMe we
found 13 loci associated with chronotype at P<5x10-8. Together with a recent study from
23andMe [14] this takes the number of replicated loci for being a morning person to 22 (7 not
reported in the 23andMe study). These loci occur in or near circadian rhythm and photorecep-
tion genes and provide new insights into circadian rhythm and sleep biology and their links to
disease.
The two novel sleep duration association signals occur upstream and downstream of VRK2
(vaccinia related kinase 2). VRK2 is a serine/threonine kinase important in several signal trans-
duction cascades, and variants near VRK2 are associated with schizophrenia [28] and epilepsy
Fig 5. LocusZoom plots of sleep duration associations in the VRK2 locus. Both plots show the same locus but each highlights a different lead variant:
rs1380703 (left) and rs17190618 (right). Variants with association P-values > 0.01 were omitted for clarity. The two leads variants represent separate
signals.
doi:10.1371/journal.pgen.1006125.g005
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[29]. The two sleep duration variants we identified do not represent the same signals as those
associated with schizophrenia at genome wide significance but one is associated with schizo-
phrenia (based on publically available data from the schizophrenia genetics consortium
(rs1380703) at P = 2x10-5, with the allele associated with more sleep being associated with
higher risk of schizophrenia). Furthermore, the variants associated with epilepsy and schizo-
phrenia at genome wide significance in previous studies are associated with sleep duration in
UK Biobank (epilepsy lead variant rs2947349 [29], P = 2x10-5 and schizophrenia lead variant
[28] rs11682175 P = 3x10-5) but did not reach genome wide significance. We also observed
genetic correlation between sleep duration and schizophrenia using LD-score regression
(rG = 0.26, P = 5x10-10). Further work is required to determine whether variation in VRK2
either has independent associations with both sleep and schizophrenia or whether there is
some causal link between sleep duration and pattern and schizophrenia and epilepsy.
Several of the loci that we identified as associated with chronotype contain genes that have a
known role in circadian rhythms. The most strongly associated variant, rs516134, occurs 20kb
downstream of RGS16 (regulator of G protein signalling 16). RGS16 has recently been shown
to have a key role in defining 24 hour rhythms in behaviour [16]. In mice, gene ablation of
Rgs16 lengthens the circadian period of behavioural rhythm [16]. By temporally regulating
cAMP signalling, Rgs16 has been shown to be a key factor in synchronising intercellular com-
munication between pacemaker neurons in the suprachiasmatic nucleus (SCN), the centre for
circadian rhythm control in humans.
The association signal with lead SNP rs75804782 occurs ~100kb upstream of PER2 (Period
2). Per2 is a key regulator of circadian rhythms and is considered one of the most important
clock genes, and, under constant darkness, Per2 knockout mice show arrhythmic locomotor
activity [17–22]. This locus also contains a variant that has recently been shown to be associ-
ated with iris furrow contractions [23]. Our signal is very likely to represent the same associa-
tion and suggests a link between iris function and chronotype (rs75804782 has an LD r2 = 0.65
and D’ = 0.97 with the reported lead SNP, rs3739070). Larsson et al. [23] suggest TRAF3IP1 as
the most likely candidate gene at the locus because of its critical role in the cytoskeleton and
neurogenesis. Further work is needed to elucidate whether the chronotype association at this
locus acts through PER2 or TRAF3IP1.
Four of the 22 chronotype loci had missense variants in LD (r2>0.8) with the lead variant
(RGS16, EXD3, INADL andHCRTR2; see S9 Table). The INADL variant association is particu-
larly interesting as INADL (InaD-like) encodes a protein that has been thought to be important
in organising and maintaining the “intrinsically photosensitive retinal ganglion cells”, cells that
are known to communicate directly with the suprachiasmatic nucleus, the primary circadian
pacemaker in mammals [30]. This is compelling evidence that INADL is involved in the
human circadian rhythm pathway.
Several of the variants associated with chronotype are also associated with BMI and we
found genetic correlation between chronotype and sleep duration and BMI. There is substan-
tial evidence for a role of sleep disruption and circadian rhythms in metabolic disease [1]. Data
from animal models and epidemiology provide strong evidence that sleep quality or disrupted
circadian rhythms can cause metabolic diseases including obesity and type 2 diabetes [4–6,8–
10]. Our Mendelian Randomisation analyses provided no consistent evidence for a role of
higher BMI leading to increased self-reported morningness. These Mendelian Randomisation
results are consistent with those from the recent study from 23andMe [14].
There are some important limitations to our study. First, chronotype and sleep duration
were self-reported and are subject to reporting bias (e.g. obese individuals may be more likely
to falsely claim to be morning people). Second, whilst we did not find any evidence that overall
chronotype or sleep duration causally lead to obesity or type 2 diabetes, it is possible that sub-
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pathways of genes involved in, for example, feeding behaviour may be important in both obe-
sity and chronotype regulation. Third, the identified variants only account for a small amount
of the variation in chronotype and sleep duration and we therefore had limited power to detect
an effect of these variants on BMI or type 2 diabetes risk. The availability of the full UK Bio-
bank study of 500,000 will provide further insight into this relationship.
In conclusion, we have identified novel genetic associations for chronotype and sleep dura-
tion. The chronotype loci cluster near genes known to be important in determining circadian
rhythms and will provide new insights into circadian regulation. Our results provide new
insights into circadian rhythm and sleep biology and their links to disease.
Materials and Methods
Ethics statement
This study was conducted using the UK Biobank resource. Details of patient and public
involvement in the UK Biobank are available online (www.ukbiobank.ac.uk/about-biobank-
uk/ and https://www.ukbiobank.ac.uk/wp-content/uploads/2011/07/Summary-EGF-
consultation.pdf). No patients were specifically involved in setting the research question or the
outcome measures, nor were they involved in developing plans for recruitment, design, or
implementation of this study. No patients were asked to advise on interpretation or writing up
of results. There are no specific plans to disseminate the results of the research to study partici-
pants, but the UK Biobank disseminates key findings from projects on its website.
Discovery samples
We used 128,266 individuals of British descent from the first UK Biobank genetic data release
(see http://biobank.ctsu.ox.ac.uk). British-descent was defined as individuals who both self-
identified as white British and were confirmed as ancestrally Caucasian using principal compo-
nents analyses (http://biobank.ctsu.ox.ac.uk). Of these individuals, 120,286 were classified as
unrelated, with a further 7,980 first- to third-degree relatives of these. As the association tests
were carried out in BOLT-LMM [31], which adjusts for relationships between individuals and
corrects for population structure, we included all 128,266 related white British individuals in
the association analyses.
Genotyping and quality control
We used imputed variants provided by the UK Biobank. Details of the imputation process are
provided at the UK Biobank website (see http://biobank.ctsu.ox.ac.uk). For this study we only
included the ~16.8M imputed variants with an imputation R2 0.4, MAF 0.001 and with a
Hardy–Weinberg equilibrium P>1x10-5.
Phenotypes
Chronotype. UK Biobank provides a single measure of Chronotype, from which we pro-
duced a continuous and a dichotomous phenotype. Chronotype (or morningness) is a self-
reported measure and asks individuals to categorise themselves as “Definitely a ‘morning’ per-
son”, “More a ‘morning’ than ‘evening’ person”, “More an ‘evening’ than a ‘morning’ person”,
“Definitely an ‘evening’ person” or “Do not know”, which we coded as 2, 1, -1, -2 and 0 respec-
tively, in our raw continuous “score”. Individuals had the option not to answer; these individu-
als were set to missing. We then produced a normally distributed phenotype by adjusting the
raw phenotype for age, gender and study centre (categorical) and inverse normalising the
resulting residuals. The dichotomous chronotype trait defines morning people (“Definitely a
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‘morning’ person” and “More a ‘morning’ than ‘evening’ person”) as cases and evening people
(“Definitely an ‘evening’ person” and “More an ‘evening’ than a ‘morning’ person”) as controls.
All other individuals are coded as missing. All results reported for continuous chronotype refer
to the inverse-normalised residualised chronotype “score”. For interpretable results, however,
we report effect sizes using the odds ratios of the dichotomous chronotype phenotype. A total
number of 127,898 and 114,765 individuals were available with non-missing continuous and
binary chronotype phenotypes, respectively, for the association tests; for the Mendelian Rando-
misation this became 119,935 and 107,634 respectively.
Sleep duration. The UK Biobank also provides self-reported “sleep duration”, in which
individuals were asked to provide the average number of hours slept in a 24-hour period. The
phenotype was derived by first excluding individuals reporting greater than 18 hours sleep,
then adjusting for age, gender and study centre (categorical) and obtaining the model residuals
and finally inverse-normalising to assure a normally distributed phenotype. When reporting
results for the continuous sleep duration phenotype, we are referring to the inverse-normalised
phenotype, though we report effect sizes of the residualised phenotype to allow easier interpre-
tation of results. There were 127,573 individuals with reported sleep duration available for the
association tests, with 119,647 available for the MR analyses.
“Oversleepers” and “undersleepers”. These two dichotomous phenotypes share the same
set of controls; those individuals that reported sleeping either 7 or 8 hours (81,204 individuals).
In oversleepers, cases (10,102 individuals) are those reporting 9 or more hours sleep on aver-
age, whereas undersleeper cases (28,980 individuals) are those reporting 6 or fewer hours.
BMI. The UK Biobank provided a BMI (weight (kg)/height2) measurement and an esti-
mate based on electrical impedance analyses. To help avoid reporting error we excluded indi-
viduals with significant differences (>4.56 SDs) between these two variables where both were
available. If only one of these measurements was available this was used. We corrected BMI by
regressing age, sex, study centre, and the first 5 within-British principal components and taking
residual values. We then inverse normalised the residuals. A total of 119,684 white-British indi-
viduals with BMI and genetic data were available for the Mendelian Randomisation analyses.
Type 2 diabetes. Individuals were defined as having T2D if they reported either T2D or
generic diabetes at the interview stage of the UK Biobank study. Individuals were excluded if
they reported insulin use within the first year of diagnosis. Individuals reportedly diagnosed
under the age of 35 years or with no known age of diagnosis were excluded, to limit the num-
bers of individuals with slow-progressing autoimmune diabetes or monogenic forms. Individu-
als diagnosed with diabetes within the last year of this study were also excluded as we were
unable to determine whether they were using insulin within this time frame. A total of 4,040
cases and 113,735 controls within the white British subset of UK Biobank were identified with
genetic data available.
Genome-wide association analysis
To perform the association tests, we used BOLT-LMM [31] to perform linear mixed models
(LMMs) in the 128,266 individuals. We used BOLT-LMM as it adjusts for population structure
and relatedness between individuals whilst performing the association tests with feasible com-
puting resources. As it adjusts for population structure and relatedness, it allowed us to include
the additional 7,980 related individuals and therefore improved our power to detect associa-
tions. To calculate the relationships between individuals, we provided BOLT-LMM a list of
328,928 genotyped SNPs (MAF>5%; HWE P>1x10-6; missingness<0.015) for the individuals
included in the association analysis and used the 1000 Genomes LD-Score table provided with
the software.
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As the continuous phenotypes were derived by adjusting for age, gender and study centre,
the LMM only included chip (BiLEVE vs. UKBiobank arrays) as a covariate at run-time (see
http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UKBiobank_genotyping_QC_
documentation-web.pdf). The binary phenotypes were unadjusted and so included age, gender
and chip at run-time. BOLT-LMM reported no improvement of the non-infinitesimal mixed
model test over the standard infinitesimal test and so all association results reported in this
paper are for the infinitesimal model [31].
Chronotype replication analyses
Participants (N = 89,283) were from the customer base of 23andMe, Inc. The descriptions of
the samples, genotyping and imputation are in [14]. Of the 16 chronotype-associated variants
for which we attempted replication, 10 were available from imputation from the 1000 Genomes
imputation panel phase 1 pilot. An additional 4 were imputed from the phase 1 version 3 1000
Genomes imputation panel. The final two could not be imputed. We used http://analysistools.
nci.nih.gov/LDlink/ to find proxies—the best available were rs4729854 for rs372229746 (r2 =
0.33), and rs12621152 for rs70944707 (r2 = 0.33). We meta-analysed P-values from the discov-
ery and replication samples using sample size weighting implemented in METAL [32].
Chronotype validation analyses
Genotypes consisting of both directly typed and imputed SNPs were used for the individual
GWAS [12]. To avoid over-inflation of test statistics due to population structure or relatedness,
we applied genomic control for the independent studies and meta-analysis. Linear regression
for associations with normalised chronotype was performed (see [12] for packages used) under
an additive model, with SNP allele dosage as predictor and with age, age2, gender, normalised
sleep duration, season of assessment (dichotomized based on time of the year, and day-light
savings time–DST or standard zone time assessments) as covariates. A fixed-effects meta-anal-
ysis was conducted with GWAMA (Genome-Wide Association Meta-Analysis) [33] using the
inverse-variance-weighted method and low imputation quality (Rsq/proper_info< 0.3) were
dropped from the meta-analysis.
Pathway and functional annotation analyses
Pathway analyses were carried out in MAGENTA[25] using all available libraries provided with
the software. We included all imputed variants with association P<1x10-5 from the continuous
chronotype trait. For the results presented in S4 Table, we used gene upstream and downstream
limits of 250Kb, excluded the HLA region (default setting) and set the number of GSEA (Gene
Set Enrichment Analysis) [34,35] permutations at 10,000 (default). We used HaploReg v4.1[36]
to annotate any coding variants within LD r2> 0.8 of the lead variant at each locus.
LocusZoom plots
LocusZoom plots (Figs 2, 3 and 5) were created using the LocusZoom tool [37] (found at
http://locuszoom.sph.umich.edu/locuszoom/) by uploading summary statistics from the
Chronotype and sleep duration GWAS. For the background LD structure, we selected the
“1000 Genomes Nov 2014 EUR” panel.
Genetic correlation analyses
Genetic correlations (see [38] for methodology) between traits were calculated using the LD
Score Regression software LDSC (available at https://github.com/bulik/ldsc/) [39]. Summary
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statistics of our traits outputted by BOLT-LMM were first “munged”, a process that converts
the summary statistics to a format that LDSC understands and aligns the alleles to the Hapmap
3 reference panel, removing structural variants and multi-allelic and strand-ambiguous SNPs.
Genetic correlations were then calculated between our phenotypes and a set of 101 phenotypes
for which summary statistics are publicly available (full list in S5 Table). We used precomputed
LD structure data files specific to Europeans of HAPMAP 3 reference panel, obtained from
(http://www.broadinstitute.org/~bulik/eur_ldscores/) as suggested on the LDSC software
website.
Mendelian Randomisation IV analysis
The 13 variants in Table 1 which reached P<5x10-8 in combined analyses were used as chron-
otype instruments in the Mendelian Randomisation analyses. Where binary and continuous
traits shared a locus, we selected the top variant of the continuous trait over that of the binary.
For loci that reach GW-significance in the binary trait only, we selected the top variant but
used the effect size from the continuous trait.
To test for a causal effect of BMI on chronotype and sleep-duration, we selected 69 of 76
common genetic variants that were associated with BMI at genome wide significance in the
GIANT consortium in studies of up to 339,224 individuals (S6 Table) [26]. We limited the
BMI SNPs to those that were associated with BMI in the analysis of all European ancestry indi-
viduals and did not include those that only reached genome-wide levels of statistical confidence
in one sex or one stratum only. Variants were also excluded if known to be classified as a sec-
ondary signal within a locus. Three variants were excluded from the score due to potential plei-
otropy (rs11030104 [BDNF reward phenotypes], rs13107325 [SLC39A8 lipids, blood pressure],
rs3888190 [SH2B1multiple traits]), three due to being out of HWE (rs17001654, rs2075650
and rs9925964) and the last variant due to not being present in the imputed data (rs2033529).
For testing reverse causality of type 2 diabetes on our sleep phenotypes, we used 55 of 65
common variants (listed in S6 Table) known to be associated with type 2 diabetes at genome
wide significance in a meta-analysis of 34,840 cases and 114,981 [27], excluding those known
or suspected to be pleiotropic.
We performed the Mendelian Randomisation analysis two ways; firstly using instrumental
variables (IV) using STATA’s “IVreg2” function [40] and secondly through the inverse-vari-
ance weighted (IVW) and MR-Egger methods described in [41]. Analyses were performed in
STATA 13.1 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: Stata-
Corp LP.).
In the instrumental variables method, we generated genetic risk scores (GRS) for BMI and
type 2 diabetes using the published list of associated variants and their respective betas. For
Chronotype, we generated a GRS using the thirteen replicated variants and their respective
betas from 23andMe summary statistics. Using the IVreg2 command, we performed two-stage
least squares estimation to calculate the effect of predicted exposure (through the GRS) on the
continuous outcome traits. For binary outcomes (type 2 diabetes, undersleeper and overslee-
per), we manually carried out the two-stage process by regressing the exposure trait on its GRS
and storing both predicted values and residuals. We then used these predicted values and resid-
uals as independent variables in a logistic regression where the dependent variable was the
binary outcome.
The inverse-variance weighted (IVW) method is equivalent to a meta-analysis of the
associations of the individual instruments and uses associations between the instruments
and both the exposure and the outcome to estimate the additive effect of the instruments
combined [41]. The MR-Egger method is a modification to the IVWmethod that allows the
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inclusion of “invalid” instruments (i.e. those that don't satisfy all three conditions), by per-
forming Egger regression using the summary data of the variants. The IVW and Egger meth-
ods operate under the assumption that all instruments are valid, in that they satisfy the three
IV conditions: the genetic variants are 1) independent of confounders, 2) associated with the
exposure and 3) independent of the outcome. The MR-Egger method, however, accounts for
the fact that genetic variants could be pleiotropic and may influence the outcome via path-
ways other than through the exposure and therefore the resulting association between
genetic instruments and the outcome should not be biased by invalid instruments and plei-
otropy. The MR-Egger method was used purely as a sensitivity test for the IVWmethod and
so MR-Egger results were not considered if the IVW result did not reach nominal
significance.
For the IVW and MR-Egger methods, associations of genetic instruments (variants) with
both exposure and outcome phenotypes were generated in STATA by regressing the phenotype
against the instrument while adjusting for covariates. As a further sensitivity test, we also
repeated these analyses by replacing exposure phenotype-variant associations with their
respective published betas and found only slight differences in betas and P-values, though all
exposure-outcome associations remained non-significant.
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S1 Table. Replication of 23andMe lead GW-significant variants (see Hu et al., 2016) [14].
The combined P-value was generated by meta-analysing the 23andMe and UKB continuous
chronotype P-values in the meta-analysis software METAL.
(XLSX)
S2 Table. Conditional analysis to identify loci independent to those reported in Hu et al.,
2016 [14].We retested our lead chronotype variants while adjusting for all 15 previously
described variants. LD r2 was calculated between our lead variant and those of 23andMe if they
were within 500kb of one another by using the 120,286 unrelated white British individuals in
UK Biobank. Significance is lost for variants rs516134, rs11162296, rs75804782, rs10157197,
rs12140153 and rs76899638 and so we consider these to belong to the same loci as previously
reported variants. Our remaining variants are still genome-wide significant.
(XLSX)
S3 Table. List of 22 loci, including 15 previously described by 23andMe and 7 in this study.
Where a locus is shared between studies, meta-analysis P-values were compared between the
lead variants and the one with lowest P-value selected.
(XLSX)
S4 Table. MAGENTA pathways reaching nominal GSEA P-value (95% cutoff) of 0.05 or
smaller, ordered by GSEA P-value (95% cutoff).
(XLSX)
S5 Table. LD Score genetic trait correlations (rG) and P-values. Correlations with P-
values< 4.95E-4 (0.05/101) are highlighted green. Those with P-values< 4.95E-3 are
highlighted yellow.
(XLSX)
S6 Table. Summary of the 76 body mass index (BMI) and 65 type 2 diabetes (T2D) SNPs
used in the Mendelian Randomisation analyses. GIANT (BMI) and DIAGRAM (T2D) betas
were used as weights in the genetic risk scores. UK Biobank betas (SEs) and P-values are
reported for inverse-normalised BMI and Chronotype; log-odds ratios (SEs) and P-values are
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dataset. External betas (log-ORs) were used as weights to generate the genetic risk scores used
in IVreg2. SNP-phenotype associations were generated in STATA using 120,286 unrelated
white British individuals.
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S8 Table. Association statistics of the 16 chronotype variants with BMI and type 2 diabetes
in the UK Biobank. Type 2 diabetes ORs and SEs were generated in a smaller subset of unre-
lated individuals as compared to the P-values, owing to limitations of Linear Mixed Models
method.
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S9 Table. Output from the Broad Institute's HaploReg tool (http://www.broadinstitute.
org/mammals/haploreg/haploreg.php) identifying missense coding variants within LD r2
 0.8 of four of the 22 lead chronotype variants.Only missense, nonsense, non-frameshift
and frameshift variants are given in this table. No coding variants were found for sleep dura-
tion.
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S1 Fig. U-shaped association between sleep duration and both self-report BMI and type 2
diabetes prevalence. Average self-report BMI (left) and type 2 diabetes prevalence (right) over
each of the sleep duration categories, calculated using the full UK Biobank cohort of 502,665
individuals. Error bars indicate standard error. Average BMI or type 2 diabetes prevalence val-
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